Back to Search Start Over

HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia.

Authors :
Ørbo A
Arnes M
Lyså LM
Borgfeldt C
Straume B
Source :
British journal of cancer [Br J Cancer] 2016 Oct 25; Vol. 115 (9), pp. e15. Date of Electronic Publication: 2016 Oct 06.
Publication Year :
2016

Details

Language :
English
ISSN :
1532-1827
Volume :
115
Issue :
9
Database :
MEDLINE
Journal :
British journal of cancer
Publication Type :
Academic Journal
Accession number :
27711084
Full Text :
https://doi.org/10.1038/bjc.2016.330